CNBC
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
EconomyDaily Composite
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
C
Source
CNBC
Read full article at CNBC
Opens original article in a new tab
Advertisement